3E033XZ
3E033XZ — Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduction of Vasopressor into Periph Vein, Perc Approach
How 3E033XZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- 3Body partThe specific site
- 3ApproachHow the site was reached
- XDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E033XZ
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E033TZIntroduction of Destructive Agent into Peripheral Vein, Percutaneous Approach
- 3E033U0Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
- 3E033U1Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
- 3E033VGIntroduction of Insulin into Peripheral Vein, Percutaneous Approach
- 3E033VHIntroduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach
- 3E033VJIntroduction of Other Hormone into Peripheral Vein, Percutaneous Approach
- 3E033WKIntroduction of Immunostimulator into Peripheral Vein, Percutaneous
- 3E033WLIntroduction of Immunosuppressive into Peripheral Vein, Percutaneous
- 3E033XZIntroduction of Vasopressor into Peripheral Vein, Percutaneous Approach
- 3E04002Introduction of High-dose Interleukin-2 into Central Vein, Open Approach
- 3E04003Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach
- 3E04005Introduction of Other Antineoplastic into Central Vein, Open Approach
- 3E0400MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach
- 3E0400PIntroduction of Clofarabine into Central Vein, Open Approach
- 3E04016Introduction of Recombinant Human-activated Protein C into Central Vein, Open
- 3E04017Introduction of Other Thrombolytic into Central Vein, Open Approach
- 3E04028Introduction of Oxazolidinones into Central Vein, Open Approach